Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

World Antiemetics Market - Opportunities and Forecasts, 2014 - 2022 - Research and Markets

Research and Markets
Posted on: 01 Nov 16

Research and Markets has announced the addition of the "World Antiemetics Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.

Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning. These drugs are often used to treat the side effects of other medications including opioid analgesics, Chemotherapy and general anesthetics. Global antiemetics market is expected to grow with healthy CAGR during the forecast period due to increase in number of patients suffering from cancer and increased number of surgeries.

In-depth discussion of global antiemetics market includes past and current trends with future forecast up to 2020. Profound assessment of threats and opportunities for new and existing companies running the business in this market would be beneficial to strategist in their respective decision making process. The report is informative towards geographical segmentation and identifies profitable areas.

Over the few years, antiemetics have witnessed sudden increase in sale due to increasing number of cancer patients. Nausea and vomiting are the common symptoms of chemotherapy and high risk chemotherapeutic agents include Carmustine and Cisplatin. Additional market drivers include extensive research activities to innovate universal antiemetic drug therapy, use of novel drug delivery to improve patient compliance and identification of new drug targets.

However, the antiemetic drugs, which are in clinical phase requires improvement in clinical trial design for their commercialization. Moreover, lack of suitable animal model that will mimic the human responses to antiemetic therapy also restraints the market growth. Novel drug therapies and new drug targets are the opportunities for manufacturers that would help them to increase their market share.

KEY BENEFITS:

  • Comprehensive coverage of global antiemetics market along with disease overview, market trends, drivers and restraints would assist strategist in their respective business decisions.
  • Thorough attention is given to leading company portfolios, pipeline research, new launches and competitive landscape of top players.
  • Explicit information on current clinical trials and R&D activities would be beneficial to understand the future market trends.
  • Insightful analysis of different segments helps to recognize and capitalize future opportunities within global antiemetics market.

For more information about this report visit http://www.researchandmarkets.com/research/vlx7xr/world_antiemetics

View source version on businesswire.com: http://www.businesswire.com/news/home/20161101006355/en/

Business Wire
www.businesswire.com

Last updated on: 01/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.